Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage

Overview of attention for article published in Genome Biology, October 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

twitter: 6 X users

patent: 4 patents

Citations

dimensions_citation: 105 Dimensions

Readers on

mendeley: 136 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

CRISPR/Cas activity assays and compositions thereof

Grant US-11807877-B1

United States of America

IMPROVED HIGH-THROUGHPUT COMBINATORIAL GENETIC MODIFICATION SYSTEM AND OPTIMIZED CAS9…

Application EP-4253549-A2

European Patent Office

PROGRAMMED CELL DEATH 1 (PD1) SPECIFIC NUCLEASES

Application EP-4234570-A2

European Patent Office

VARIANT CAS9

Application WO-2021171048-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.